|
Market Closed -
Nasdaq Stockholm
12:00:00 2026-09-22 EDT
|
5-day change | 1st Jan Change | ||
| 0.3990 SEK | +1.01% |
|
-2.44% | +31.25% |
Company Valuation: Modus Therapeutics Holding AB
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Market Cap 1 | 61.18 | 44.92 | 62.35 | 64.87 | 36.98 |
| Change | - | -26.58% | 38.81% | 4.03% | -43% |
| Enterprise Value (EV) 1 | 40.53 | 46 | 43.29 | 60.49 | 25.6 |
| Change | - | 13.48% | -5.87% | 39.72% | -57.68% |
| P/E | -2.27x | -2.45x | -1.72x | -4.17x | -1.03x |
| PBR | 3.89x | -17.4x | 3.53x | 30.4x | 4.08x |
| PEG | -0x | 0.1x | 0.2x | 0.1x | 0x |
| Capitalization / Revenue | - | - | - | - | - |
| EV / Revenue | - | - | - | - | - |
| EV / EBITDA | - | - | - | - | - |
| EV / EBIT | -1.96x | -2.55x | -2.64x | -3.82x | -1.41x |
| EV / FCF | -4.87x | -3.1x | -3.83x | -6.7x | -2.21x |
| FCF Yield | -20.5% | -32.3% | -26.1% | -14.9% | -45.3% |
| Dividend per Share 2 | - | - | - | - | - |
| Rate of return | - | - | - | - | - |
| EPS 2 | -1.672 | -1.138 | -1.009 | -0.4325 | -0.296 |
| Distribution rate | - | - | - | - | - |
| Net sales | - | - | - | - | - |
| EBITDA | - | - | - | - | - |
| EBIT 1 | -20.69 | -18.01 | -16.4 | -15.84 | -18.14 |
| Net income 1 | -20.69 | -18.32 | -17.9 | -15.54 | -18.54 |
| Net Debt 1 | -20.65 | 1.076 | -19.06 | -4.379 | -11.37 |
| Reference price 2 | 3.8000 | 2.7900 | 1.7350 | 1.8050 | 0.3040 |
| Nbr of stocks (in thousands) | 16,100 | 16,100 | 35,939 | 35,939 | 121,628 |
| Announcement Date | 4/19/22 | 4/14/23 | 4/11/24 | 4/15/25 | 4/15/26 |
1SEK in Million2SEK
Estimates
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | - | - | - | 6.02M | |
| 32.07x | 5.77x | 17.28x | 1.01% | 47.86B | |
| 34.76x | 3.35x | 14.44x | -.--% | 44.46B | |
| 47.9x | 5.56x | 30.41x | -.--% | 41.85B | |
| -19.81x | 213.44x | -21.53x | -.--% | 41.34B | |
| 27.45x | 7.91x | 20.36x | 0.41% | 30.04B | |
| 35.5x | 5.83x | 26.48x | -.--% | 17.59B | |
| 26.02x | 2.23x | 9.67x | 1.03% | 15.69B | |
| -56.03x | 9.2x | 224.52x | -.--% | 13.93B | |
| Average | 15.98x | 31.66x | 40.20x | 0.31% | 28.08B | |
| Weighted average by Cap. | 21.14x | 39.50x | 24.56x | 0.3% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- MODTX Stock
- Valuation Modus Therapeutics Holding AB
Select your edition
All financial news and data tailored to specific country editions
